This is consistent with our microarray results showing for instance an increased expression of Cxcl10, which similarly to PF4 exerts a potent pro-inflammatory and anti-angiogenic action that has been involved in the pathophysiology of preeclampsia [44]. The gene discussed is PF4; the disease is preeclampsia.